5IVR

Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methylamino]-4-hydroxy-butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.5 Å
  • R-Value Free: 0.207 
  • R-Value Work: 0.193 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group.

Bungard, C.J.Williams, P.D.Ballard, J.E.Bennett, D.J.Beaulieu, C.Bahnck-Teets, C.Carroll, S.S.Chang, R.K.Dubost, D.C.Fay, J.F.Diamond, T.L.Greshock, T.J.Hao, L.Holloway, M.K.Felock, P.J.Gesell, J.J.Su, H.P.Manikowski, J.J.McKay, D.J.Miller, M.Min, X.Molinaro, C.Moradei, O.M.Nantermet, P.G.Nadeau, C.Sanchez, R.I.Satyanarayana, T.Shipe, W.D.Singh, S.K.Truong, V.L.Vijayasaradhi, S.Wiscount, C.M.Vacca, J.P.Crane, S.N.McCauley, J.A.

(2016) Acs Med.Chem.Lett. 7: 702-707

  • DOI: 10.1021/acsmedchemlett.6b00135
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • A novel HIV protease inhibitor was designed using a morpholine core as the aspartate binding group. Analysis of the crystal structure of the initial lead bound to HIV protease enabled optimization of enzyme potency and antiviral activity. This afford ...

    A novel HIV protease inhibitor was designed using a morpholine core as the aspartate binding group. Analysis of the crystal structure of the initial lead bound to HIV protease enabled optimization of enzyme potency and antiviral activity. This afforded a series of potent orally bioavailable inhibitors of which MK-8718 was identified as a compound with a favorable overall profile.


    Organizational Affiliation

    Merck Research Laboratories , 770 Sumneytown Pike, PO Box 4, West Point, Pennsylvania 19486, United States.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Protease
A, B
99Human immunodeficiency virus 1Mutation(s): 0 
Gene Names: pol
Find proteins for Q77VV3 (Human immunodeficiency virus 1)
Go to UniProtKB:  Q77VV3
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
CL
Query on CL

Download SDF File 
Download CCD File 
A, B
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
 Ligand Interaction
6EG
Query on 6EG

Download SDF File 
Download CCD File 
B
N-{2-[(3S)-3-{[(4-aminophenyl)methyl]amino}-4-hydroxybutyl]phenyl}-Nalpha-(methoxycarbonyl)-beta-phenyl-L-phenylalaninamide
C34 H38 N4 O4
OMLKMYZREOOQQQ-NYDCQLBNSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.5 Å
  • R-Value Free: 0.207 
  • R-Value Work: 0.193 
  • Space Group: P 21 21 2
Unit Cell:
Length (Å)Angle (°)
a = 58.190α = 90.00
b = 85.960β = 90.00
c = 46.350γ = 90.00
Software Package:
Software NamePurpose
BUSTERphasing
BUSTERrefinement
XDSdata reduction
Aimlessdata scaling
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2016-03-21 
  • Released Date: 2016-05-18 
  • Deposition Author(s): Su, H.P.

Revision History 

  • Version 1.0: 2016-05-18
    Type: Initial release
  • Version 1.1: 2016-08-10
    Type: Database references